iZafe Group AB (publ) announced today that its subsidiary Dosell AB has entered into an agreement with the municipalities of Mora, Orsa, and Älvdalen. Dosell was selected as the winning supplier in the municipalities’ joint procurement of medication dispensers with associated remote care systems. The contract period is estimated to require approximately 120 units.
The procurement was conducted through Adda Inköpscentral’s national framework agreement “Medication Dispensers with Remote Care Systems 2025”. Dosell was chosen as the sole supplier after an overall evaluation of price and quality.
The estimated requirement will be distributed across the three municipalities, with approximately 70 units in Mora, 30 in Orsa, and 20 in Älvdalen. However, these volumes are not guaranteed.
The contract will run from December 1, 2026, to November 30, 2028, with an option to extend it by one year at a time until November 30, 2030. Implementation is expected to take place gradually during the winter and spring of 2026/2027.
Anders Segerström, CEO of iZafe Group AB, stated that this contract is a clear validation of their offering and showcases how Adda’s national framework agreement is being translated into municipal contracts. He further added that their focus now is on ensuring a safe and phased implementation.
Mora, Orsa, and Älvdalen have experience with medication dispensers and cover large geographical areas with long distances between users and care staff. Dosell’s solution aims to increase independence for users while allowing health and social care staff to prioritize their resources more effectively.
Dosell is a connected medication dispenser that provides dose-packaged medicines at the prescribed time, reminds the user, and can issue an alert if a dose is missed. This solution is designed to enhance patient safety and independence while making medication management in health and social care more efficient.
For more information, please contact:
Anders Segerström, CEO
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
David Bagares gata 31
111 38 Stockholm
E-mail: ir@izafegroup.com
www.izafegroup.com
eucaps.com/izafe-group
About iZafe Group AB (publ.)
iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.
The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company’s solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.
The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.
iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. The company’s Certified Adviser is DNB Carnegie Investment Bank AB. Further information is available at www.izafegroup.com.
